Celexa, Lexapro Deal Covers Civil Claims Only

Law360, New York (November 9, 2009, 3:18 PM EST) -- Forest Laboratories Inc. and the U.S. Department of Justice have struck a deal to settle civil claims stemming from investigations into the marketing of antidepressants Celexa and Lexapro and a hypothyroidism treatment, but the pact does not cover an ongoing probe into possible criminal violations related to the drugs.

Forest disclosed that it had reached an agreement in principle with the U.S. Attorney's Office for the District of Massachusetts and the DOJ's Civil Division in a quarterly report filed with the Securities and Exchange Commission on...
To view the full article, register now.